HL
Harding Loevner’s CME Group CME Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261M | Buy |
946,808
+17,444
| +2% | +$4.81M | 1.76% | 18 |
|
|
2025
Q1 | $247M | Sell |
929,364
-170,511
| -16% | -$45.2M | 1.89% | 19 |
|
|
2024
Q4 | $255M | Sell |
1,099,875
-219,288
| -17% | -$50.9M | 1.73% | 20 |
|
|
2024
Q3 | $291M | Buy |
1,319,163
+197,050
| +18% | +$43.5M | 1.68% | 20 |
|
|
2024
Q2 | $221M | Sell |
1,122,113
-36,845
| -3% | -$7.24M | 1.22% | 31 |
|
|
2024
Q1 | $250M | Sell |
1,158,958
-95,781
| -8% | -$20.6M | 1.54% | 25 |
|
|
2023
Q4 | $264M | Sell |
1,254,739
-22,669
| -2% | -$4.77M | 1.48% | 24 |
|
|
2023
Q3 | $256M | Sell |
1,277,408
-177,538
| -12% | -$35.5M | 1.69% | 22 |
|
|
2023
Q2 | $270M | Sell |
1,454,946
-224,674
| -13% | -$41.6M | 1.57% | 22 |
|
|
2023
Q1 | $322M | Buy |
1,679,620
+625,583
| +59% | +$120M | 1.83% | 19 |
|
|
2022
Q4 | $177M | Buy |
1,054,037
+109,192
| +12% | +$18.4M | 1.02% | 38 |
|
|
2022
Q3 | $167M | Sell |
944,845
-54,634
| -5% | -$9.68M | 1.1% | 29 |
|
|
2022
Q2 | $205M | Sell |
999,479
-313,819
| -24% | -$64.2M | 1.26% | 24 |
|
|
2022
Q1 | $266M | Sell |
1,313,298
-111,506
| -8% | -$22.6M | 1.47% | 24 |
|
|
2021
Q4 | $326M | Sell |
1,424,804
-28,894
| -2% | -$6.6M | 1.25% | 32 |
|
|
2021
Q3 | $281M | Sell |
1,453,698
-82,725
| -5% | -$16M | 1.12% | 32 |
|
|
2021
Q2 | $327M | Sell |
1,536,423
-986,293
| -39% | -$210M | 1.23% | 30 |
|
|
2021
Q1 | $515M | Buy |
2,522,716
+759,390
| +43% | +$155M | 2.02% | 20 |
|
|
2020
Q4 | $321M | Buy |
1,763,326
+177,375
| +11% | +$32.3M | 1.33% | 26 |
|
|
2020
Q3 | $265M | Buy |
+1,585,951
| New | +$265M | 0.96% | 34 |
|